✦ LIBER ✦

Pharmacotherapy of triple-negative breast cancer

✍ Scribed by Arslan, Cagatay; Dizdar, Omer; Altundag, Kadri

Book ID: 118144368
Publisher: Informa plc
Year: 2009
Tongue: English
Weight: 481 KB
Volume: 10
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656560903117309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple-negative breast cancer

✍ Rupert Bartsch; Reinhard Ziebermayr; Christoph C. Zielinski; Guenther G. Steger 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 165 KB

Triple Negative Breast Cancer

✍ S. Ressler; B. Mlineritsch; R. Greil 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 193 KB

Metastatic Triple-negative Breast Cancer

✍ E.A. Rakha; S. Chan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Management of triple negative breast can

Management of triple negative breast cancer

✍ Catherine Oakman; Giuseppe Viale; Angelo Di Leo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Characteristics of triple-negative breas

Characteristics of triple-negative breast cancer

✍ Tim C. de Ruijter; Jürgen Veeck; Joep P. J. de Hoon; Manon van Engeland; Viviann 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 254 KB

## Background Triple-negative breast cancers (TNBC) neither express hormone receptors, nor overexpress HER2. They are associated with poor prognosis, as defined by low five-year survival and high recurrence rates after adjuvant therapy. Overall, TNBC share striking similarities with basal-like brea

Treatment of triple-negative breast canc

Treatment of triple-negative breast cancer

✍ Natalyn Hawk; Ruth O'Regan 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 75 KB